EUVIMEDEUVIMED entdecken
Crossref

Co-Former Selection And Optimization Strategies For Solubility Enhancement Of Drugs: A Review

Shivpuje Shivraj S., Patwekar Shailesh L., Pawde Pradip S., Bansode Santosh S., Pohekar Abhijeet S., Waman Rahul L.

International Journal of Drug Delivery Technology · 09.04.2026 · 16 (6s)

DOI: 10.25258/ijddt.16.6s.94 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 09.04.2026. Verfasst von Shivpuje Shivraj S. und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poor aqueous solubility continues to hinder the development of many oral drug formulations, restricting both their bioavailability and therapeutic performance. One approach that has attracted increasing attention is cocrystallization, which can alter key physicochemical properties of a compound without changing its pharmacological profile. In this review, we examine how molecular docking and related computational methods can be used to guide the rational choice of co-formers in co-crystal design. Docking studies shed light on binding strength, hydrogenbond preferences, and other intermolecular interactions, thereby helping to narrow down the pool of potential drug– co-former combinations. We highlight examples involving carboxylic acids, amino acids, and GRAS-listed coformers, while also pointing out where computational predictions fall short of experimental outcomes, particularly due to limited co-former diversity. Experimental techniques such as PXRD, DSC, and SCXRD are considered alongside current regulatory guidance from the FDA and EMA, since both scientific feasibility and regulatory acceptance are critical to successful development. We conclude by discussing the need to combine docking with molecular dynamics, crystal structure prediction, and machine learning approaches, which together may yield more reliable predictions. Unlike earlier reviews that typically emphasize either computational or experimental perspectives, our aim is to integrate both, and to place them within the broader regulatory context, in order to provide a practical framework for co-former selection.

Zitieren

APA

S., S. S., L., P. S., S., P. P., S., B. S., S., P. A., & L., W. R. (2026). Co-Former Selection And Optimization Strategies For Solubility Enhancement Of Drugs: A Review. International Journal of Drug Delivery Technology, 16(6s). https://doi.org/10.25258/ijddt.16.6s.94

Vancouver

S. SS, L. PS, S. PP, S. BS, S. PA, L. WR. Co-Former Selection And Optimization Strategies For Solubility Enhancement Of Drugs: A Review. International Journal of Drug Delivery Technology. 2026;16(6s). doi:10.25258/ijddt.16.6s.94

BibTeX
@article{S2026,
  author = {S., Shivpuje Shivraj and L., Patwekar Shailesh and S., Pawde Pradip and S., Bansode Santosh and S., Pohekar Abhijeet and L., Waman Rahul},
  title = {Co-Former Selection And Optimization Strategies For Solubility Enhancement Of Drugs: A Review},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {6s},
  doi = {10.25258/ijddt.16.6s.94}
}
Kostenlos starten →